VCRB yields 4.55% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VCRB + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCRB + MRK for your $10,000?
This actively managed fund seeks to provide broadly diversified exposure predominantly to the U.S. investment-grade bond market. The low-cost fund invests in U.S. Treasury, mortgage-backed, and corporate securities of varying yields and maturities (short-, intermediate-, and long-term issues). Using a disciplined, risk-controlled approach, the fund seeks to outperform the broad investment-grade market through security selection, sector allocation, and, to a lesser extent, duration decisions. Like other bond funds, the fund is subject to interest rate risk; increases in interest rates may cause the price of the bonds in the portfolio to decrease, reducing the fund’s NAV. Since the fund invests in all major segments and maturities of the investment-grade fixed income market, investors may consider the fund as a core bond holding.The Core Bond ETF is a stand alone product and is separate and distinct from the Vanguard Core Bond Fund (VCOBX and VCORX). Differences in scale, certain investment processes, and underlying holdings are expected to produce different investment returns by the funds.
Full VCRB Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.